(Q28271532)

English

Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation (English)

0 references

1 reference

Kenichi Suda

0 references

Kenji Tomizawa

series ordinal

0 references

Tetsuya Mitsudomi

series ordinal

0 references

language of work or name

English

0 references

publication date

March 2010

0 references

published in

Cancer and Metastasis Reviews

0 references

volume

0 references

issue

0 references

page(s)

49-60

0 references

cites work

The ras gene family and human carcinogenesis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10555-010-9209-4

retrieved

21 January 2018

Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10555-010-9209-4

retrieved

21 January 2018

Tumour biology: senescence in premalignant tumours

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/436642A

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1158/1078-0432.CCR-08-0168

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28271532&oldid=2177571738"